Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled, Post-marketing Phase III Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly in Adults.
Brief Summary: As a result of the recent supply shortages in the U.S., as well as an anticipated increase in demand during the coming years, GSK Biologicals is pursuing licensure of Fluarix in the U.S. under the accelerated approval process; marketing approval most likely will be granted before the start of this clinical trial. GSK proposes to support U.S. licensure of Fluarix with this confirmatory post-marketing study. The purpose of the study is to evaluate the efficacy of a single dose of Fluarix in preventing influenza in adults during the 2005/2006 Influenza season.


Options:
A: Arm Label: VAX128; Type: EXPERIMENTAL; Interventions: Biological: VAX128 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: VAX128; Assigned to Arm(s): VAX128 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: CSL Limited Influenza Vaccine | Arm Label: 2; Type: OTHER; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: CSL Limited Influenza Vaccine; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: pandemic vaccine 1; Type: EXPERIMENTAL; Interventions: Biological: pandemic vaccine 1 | Arm Label: pandemic vaccine 2; Type: EXPERIMENTAL; Interventions: Biological: pandemic vaccine 2 | Arm Label: pandemic vaccine 5; Type: EXPERIMENTAL; Interventions: Biological: pandemic vaccine 5 | Arm Label: pandemic vaccine 6; Type: EXPERIMENTAL; Interventions: Biological: pandemic vaccine 6 | Arm Label: pandemic vaccine 9; Type: EXPERIMENTAL; Interventions: Biological: pandemic vaccine 9 | Arm Label: pandemic vaccine 10; Type: EXPERIMENTAL; Interventions: Biological: pandemic vaccine 10 | Arm Label: pandemic vaccine 11; Type: EXPERIMENTAL; Interventions: Biological: pandmeic vaccine 11 | Arm Label: pandemic vaccine 12; Type: EXPERIMENTAL; Interventions: Biological: pandmeic vaccine 12 | Arm Label: pandemic vaccine 13; Type: EXPERIMENTAL; Interventions: Biological: pandmic vaccine 13 | Arm Label: placebo group 14; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo group 14 | Intervention Type: BIOLOGICAL; Name: pandemic vaccine 1; Assigned to Arm(s): pandemic vaccine 1 | Intervention Type: BIOLOGICAL; Name: pandemic vaccine 2; Assigned to Arm(s): pandemic vaccine 2 | Intervention Type: BIOLOGICAL; Name: pandemic vaccine 5; Assigned to Arm(s): pandemic vaccine 5 | Intervention Type: BIOLOGICAL; Name: pandemic vaccine 6; Assigned to Arm(s): pandemic vaccine 6 | Intervention Type: BIOLOGICAL; Name: pandemic vaccine 9; Assigned to Arm(s): pandemic vaccine 9 | Intervention Type: BIOLOGICAL; Name: pandemic vaccine 10; Assigned to Arm(s): pandemic vaccine 10 | Intervention Type: BIOLOGICAL; Name: pandmeic vaccine 11; Assigned to Arm(s): pandemic vaccine 11 | Intervention Type: BIOLOGICAL; Name: pandmeic vaccine 12; Assigned to Arm(s): pandemic vaccine 12 | Intervention Type: BIOLOGICAL; Name: pandmic vaccine 13; Assigned to Arm(s): pandemic vaccine 13 | Intervention Type: BIOLOGICAL; Name: placebo group 14; Assigned to Arm(s): placebo group 14
D: Intervention Type: BIOLOGICAL; Name: Influenza vaccine; Assigned to Arm(s): N/A

Answer: D